| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |